Click here for a description of the charts and data table
Please tell us if you are using this feature and what you think!
ChEMBL ligand: CHEMBL509 (CI-583, CL-583, INF 4668, INF-4668, Meclodium, Meclofenamate, Meclofenamic acid, Meclomen, NSC-95309) |
---|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
DB | Assay description | Assay Type | Standard value | Standard parameter | Original value | Original units | Original parameter | Reference |
---|---|---|---|---|---|---|---|---|
Aldo-keto reductase family 1 member C1 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL5905] [UniProtKB: Q04828] | ||||||||
ChEMBL | Inhibition of human recombinant N-terminal His6-tagged AKR1C1 expressed in Escherichia coli BL21(DE3) cells using 8-Acetyl-2,3,5,6-tetrahydro-1H,4H-11-oxa-3a-aza-benzo[de]anthracen-10-one as substrate after 1 hr by fluorimetric analysis | B | 5.5 | pIC50 | 3160 | nM | IC50 | J Med Chem (2012) 55: 7746-7758 [PMID:22877157] |
ChEMBL | Inhibition of AKR1C1 (unknown origin) | B | 5.5 | pIC50 | 3160 | nM | IC50 | Eur J Med Chem (2013) 62: 738-744 [PMID:23454516] |
ChEMBL | Inhibition of recombinant human AKR1C1 expressed in Escherichia coli BL21 cells in presence of 9,10-phenanthrenequinone and NADPH by fluorescence assay | B | 6.13 | pIC50 | 740 | nM | IC50 | Bioorg Med Chem (2018) 26: 5934-5943 [PMID:30429100] |
Aldo-keto reductase family 1 member C2 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL5847] [UniProtKB: P52895] | ||||||||
ChEMBL | Inhibition of human recombinant N-terminal His6-tagged AKR1C2 expressed in Escherichia coli BL21(DE3) cells using 8-Acetyl-2,3,5,6-tetrahydro-1H,4H-11-oxa-3a-aza-benzo[de]anthracen-10-one as substrate after 1 hr by fluorimetric analysis | B | 5.06 | pIC50 | 8740 | nM | IC50 | J Med Chem (2012) 55: 7746-7758 [PMID:22877157] |
ChEMBL | Inhibition of AKR1C2 (unknown origin) | B | 5.06 | pIC50 | 8740 | nM | IC50 | Eur J Med Chem (2013) 62: 738-744 [PMID:23454516] |
AKR1C3/Aldo-keto-reductase family 1 member C3 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL4681] [GtoPdb: 1382] [UniProtKB: P42330] | ||||||||
ChEMBL | Inhibition of human recombinant N-terminal His6-tagged AKR1C3 expressed in Escherichia coli BL21(DE3) cells using 8-Acetyl-2,3,5,6-tetrahydro-1H,4H-11-oxa-3a-aza-benzo[de]anthracen-10-one as substrate after 1 hr by fluorimetric analysis | B | 6.27 | pIC50 | 540 | nM | IC50 | J Med Chem (2012) 55: 7746-7758 [PMID:22877157] |
ChEMBL | Inhibition of AKR1C3 (unknown origin) | B | 6.27 | pIC50 | 540 | nM | IC50 | Eur J Med Chem (2013) 62: 738-744 [PMID:23454516] |
ChEMBL | Inhibition of recombinant human AKR1C3 expressed in Escherichia coli BL21 cells in presence of 9,10-phenanthrenequinone and NADPH by fluorescence assay | B | 6.29 | pIC50 | 512 | nM | IC50 | Bioorg Med Chem (2018) 26: 5934-5943 [PMID:30429100] |
Aldo-keto reductase family 1 member C4 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL4999] [UniProtKB: P17516] | ||||||||
ChEMBL | Inhibition of human recombinant N-terminal His6-tagged AKR1C4 expressed in Escherichia coli BL21(DE3) cells using 8-Acetyl-2,3,5,6-tetrahydro-1H,4H-11-oxa-3a-aza-benzo[de]anthracen-10-one as substrate after 1 hr by fluorimetric analysis | B | 4 | pIC50 | >100000 | nM | IC50 | J Med Chem (2012) 55: 7746-7758 [PMID:22877157] |
ChEMBL | Inhibition of AKR1C4 (unknown origin) | B | 4 | pIC50 | >100000 | nM | IC50 | Eur J Med Chem (2013) 62: 738-744 [PMID:23454516] |
5-LOX/Arachidonate 5-lipoxygenase in Rat (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL312] [GtoPdb: 1385] [UniProtKB: P12527] | ||||||||
ChEMBL | Compound was evaluated for its inhibitory activity against 5-LO (5-lipoxygenase) | B | 4.62 | pIC50 | 24000 | nM | IC50 | Bioorg Med Chem Lett (1992) 2: 705-708 |
ChEMBL | Compound was evaluated in an intact RBL-1 cell line for inhibition of 5-lipoxygenase | B | 4.62 | pIC50 | 24000 | nM | IC50 | Bioorg Med Chem Lett (1992) 2: 69-72 |
ChEMBL | Inhibition 5-lipoxygenase mediated LTB4 formation in rat basophilic leukemia (RBL-1) cells | B | 4.62 | pIC50 | 24000 | nM | IC50 | J Med Chem (1993) 36: 1802-1810 [PMID:8515419] |
ChEMBL | Inhibition of 5-lipoxygenase measured by the reduction of leukotriene B4 (LTB4) in intact basophilic rat leukemia cells | F | 4.62 | pIC50 | 24000 | nM | IC50 | J Med Chem (1993) 36: 1090-1099 [PMID:8478906] |
COX-1 /Cyclooxygenase-1 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL221] [GtoPdb: 1375] [UniProtKB: P23219] | ||||||||
ChEMBL | Inhibition of COX1 (unknown origin) | B | 6.66 | pIC50 | 220 | nM | IC50 | Eur J Med Chem (2013) 62: 738-744 [PMID:23454516] |
ChEMBL | DRUGMATRIX: Cyclooxygenase COX-1 enzyme inhibition (substrate: Arachidonic acid) | B | 6.69 | pIC50 | 203 | nM | IC50 | DrugMatrix in vitro pharmacology data |
GtoPdb | - | - | 7.3 | pIC50 | 50 | nM | IC50 | Bioorg Med Chem Lett (2002) 12: 521-4 [PMID:11844663] |
Cyclooxygenase-1 in Sheep (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL2949] [UniProtKB: P05979] | ||||||||
ChEMBL | Inhibition of the ovine Prostaglandin G/H synthase 1 was determined by thin-layer chromatography assay | B | 7.3 | pIC50 | 50 | nM | IC50 | Bioorg Med Chem Lett (2002) 12: 521-524 [PMID:11844663] |
COX-2 /Cyclooxygenase-2 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL230] [GtoPdb: 1376] [UniProtKB: P35354] | ||||||||
ChEMBL | Inhibition of COX2 (unknown origin) | B | 6.15 | pIC50 | 700 | nM | IC50 | Eur J Med Chem (2013) 62: 738-744 [PMID:23454516] |
ChEMBL | Inhibition of the human Prostaglandin G/H synthase 2 was determined by thin-layer chromatography assay | B | 7.4 | pIC50 | 40 | nM | IC50 | Bioorg Med Chem Lett (2002) 12: 521-524 [PMID:11844663] |
GtoPdb | - | - | 7.4 | pIC50 | 40 | nM | IC50 | Bioorg Med Chem Lett (2002) 12: 521-4 [PMID:11844663] |
ChEMBL | DRUGMATRIX: Cyclooxygenase COX-2 enzyme inhibition (substrate: Arachidonic acid) | B | 7.96 | pIC50 | 11 | nM | IC50 | DrugMatrix in vitro pharmacology data |
COX-2 /Cyclooxygenase-2 in Mouse (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL4321] [GtoPdb: 1376] [UniProtKB: Q05769] | ||||||||
ChEMBL | Inhibition of the murine Arg120Ala mutant type COX-2 | B | 6.4 | pIC50 | 400 | nM | IC50 | Bioorg Med Chem Lett (2002) 12: 521-524 [PMID:11844663] |
ChEMBL | Inhibition of the murine wild type Prostaglandin G/H synthase 2 | B | 6.7 | pIC50 | 200 | nM | IC50 | Bioorg Med Chem Lett (2002) 12: 521-524 [PMID:11844663] |
fatty acid binding protein 2/Fatty acid binding protein intestinal in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL4879] [GtoPdb: 2532] [UniProtKB: P12104] | ||||||||
ChEMBL | Displacement of 1-anilinonaphthalene-8-sulphonic acid from I-FABP | B | 5.05 | pKi | 8900 | nM | Ki | J Med Chem (2008) 51: 3755-3764 [PMID:18533710] |
fatty acid binding protein 1/Fatty acid-binding protein, liver in Rat (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL5738] [GtoPdb: 2531] [UniProtKB: P02692] | ||||||||
ChEMBL | Displacement of 1-anilinonaphthalene-8-sulphonic acid from rat recombinant L-FABP high binding affinity site expressed in Escherichia coli BL21 by competitive fluorescence displacement assay | B | 6.42 | pKi | 379 | nM | Ki | J Med Chem (2008) 51: 3755-3764 [PMID:18533710] |
ChEMBL | Displacement of 1-anilinonaphthalene-8-sulphonic acid from rat recombinant L-FABP low binding affinity site expressed in Escherichia coli BL21 by competitive fluorescence displacement assay | B | 6.59 | pKi | 256 | nM | Ki | J Med Chem (2008) 51: 3755-3764 [PMID:18533710] |
mitogen-activated protein kinase 1/MAP kinase ERK2 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL4040] [GtoPdb: 1495] [UniProtKB: P28482] | ||||||||
ChEMBL | DRUGMATRIX: Protein Serine/Threonine Kinase, ERK2 enzyme inhibition (substrate: Myelin Basic Protein) | B | 5.5 | pIC50 | 3144 | nM | IC50 | DrugMatrix in vitro pharmacology data |
transthyretin/Transthyretin in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL3194] [GtoPdb: 2851] [UniProtKB: P02766] | ||||||||
ChEMBL | Binding affinity to TTR (unknown origin) by isothermal titration calorimetric analysis | B | 6.32 | pKd | 480 | nM | Kd | J Med Chem (2015) 58: 6507-6515 [PMID:26214366] |
ChEMBL | Binding affinity to TTR in human plasma assessed as protein stabilization preincubated for 1 hr followed by urea-mediated denaturation by Western blot analysis | B | 4.3 | pIC50 | 50000 | nM | IC50 | J Med Chem (2015) 58: 6507-6515 [PMID:26214366] |
TRPM4 in Human [GtoPdb: 496] [UniProtKB: Q8TD43] | ||||||||
GtoPdb | - | - | 5.47 | pIC50 | 3420 | nM | IC50 | Eur Heart J (2022) 43: 4195-4207 [PMID:35822895] |
ChEMBL data shown on this page come from version 32:
Mendez D, Gaulton A, Bento AP, Chambers J, De Veij M, Félix E, Magariños MP, Mosquera JF, Mutowo P, Nowotka M, Gordillo-Marañón M, Hunter F, Junco L, Mugumbate G, Rodriguez-Lopez M, Atkinson F, Bosc N, Radoux CJ, Segura-Cabrera A, Hersey A, Leach AR. (2019) 'ChEMBL: towards direct deposition of bioassay data' Nucleic Acids Res., 47(D1). DOI: 10.1093/nar/gky1075. [EPMCID:30398643]
Davies M, Nowotka M, Papadatos G, Dedman N, Gaulton A, Atkinson F, Bellis L, Overington JP. (2015) 'ChEMBL web services: streamlining access to drug discovery data and utilities.' Nucleic Acids Res., 43(W1). DOI: 10.1093/nar/gkv352. [EPMCID:25883136]